These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10802894)

  • 21. [The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women].
    Okoń A; Jurowski P; Goś R
    Klin Oczna; 2001; 103(4-6):183-6. PubMed ID: 11975014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiovascular diseases and hormone replacement therapy in females].
    Szücs J
    Orv Hetil; 1995 Feb; 136(8 Suppl 1):455-7. PubMed ID: 7877817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy in breast cancer survivors.
    Xydakis AM; Sakkas EG; Mastorakos G
    Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of hormone replacement therapy on the pathophysiology of peripheral arterial disease.
    Davies RS; Vohra RK; Bradbury AW; Adam DJ
    Eur J Vasc Endovasc Surg; 2007 Nov; 34(5):569-75. PubMed ID: 17681824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of stroke and hormone replacement therapy. A prospective cohort study.
    Li C; Engström G; Hedblad B; Berglund G; Janzon L
    Maturitas; 2006 Apr; 54(1):11-8. PubMed ID: 16321486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women.
    Sator PG; Sator MO; Schmidt JB; Nahavandi H; Radakovic S; Huber JC; Hönigsmann H
    Climacteric; 2007 Aug; 10(4):320-34. PubMed ID: 17653959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HRT as secondary prevention of cardiovascular disease.
    Ylikorkala O
    Maturitas; 2004 Apr; 47(4):315-8. PubMed ID: 15063485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormone replacement therapy and venous thromboembolism].
    Trillot N; Susen S; Jude B
    Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy and cardiovascular health in the United States.
    Shetty KD; Vogt WB; Bhattacharya J
    Med Care; 2009 May; 47(5):600-6. PubMed ID: 19319001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy: to use or not to use?
    Baber RJ; O'Hara JL; Boyle FM
    Med J Aust; 2003 Jun; 178(12):630-3. PubMed ID: 12797851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F; Gerson M
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Right or wrong of the hormone replacement therapy involving osteoporosis].
    Hoshino S; Ouchi Y
    Clin Calcium; 2004 Nov; 14(11):87-98. PubMed ID: 15577164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
    Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
    J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
    Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine.
    Liu P; He FF; Bai WP; Yu Q; Shi W; Wu YY; He DJ; Xiao JH; Zheng Y; Liao QP
    Chin Med J (Engl); 2004 Feb; 117(2):189-94. PubMed ID: 14975200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of caregiving stress and hormone replacement therapy is associated with prolonged platelet activation to acute stress among postmenopausal women.
    Aschbacher K; von Känel R; Mills PJ; Hong S; Roepke SK; Mausbach BT; Patterson TL; Ziegler MG; Dimsdale JE; Ancoli-Israel S; Grant I
    Psychosom Med; 2007 Dec; 69(9):910-7. PubMed ID: 17991824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estrogen replacement therapy: for whom, why and how?].
    Rozenberg S; Neusy S; Barudy J; Fellemans C; Jahjah L
    Rev Med Brux; 2002 Sep; 23(4):A382-9. PubMed ID: 12422465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.